# Risk factors for deep venous thrombosis in spontaneous intracerebral hemorrhage and their long-term prognostic implications

**Authors:** Xianju Liang, Chuyue Wu, Yu Huang, Jing Wang, Lei He, Wei Feng

PMC · DOI: 10.1515/med-2025-1341 · Open Medicine · 2026-02-11

## TL;DR

This study finds that certain factors increase the risk of venous thrombosis in patients with brain hemorrhage, and those with thrombosis face worse long-term recovery outcomes.

## Contribution

The study identifies specific risk factors for venous thrombosis in ICH patients and shows their association with poor long-term outcomes.

## Key findings

- Extended hospital stay, higher NIH Stroke Scale score, and elevated D-dimer levels are risk factors for venous thrombosis in ICH patients.
- Venous thrombosis is linked to worse functional outcomes at discharge, 90 days, and one year after onset.
- Mortality rates were not significantly different between patients with and without venous thrombosis.

## Abstract

This study sought to identify the risk factors associated with venous thrombosis for spontaneous intracerebral hemorrhage (ICH) in a long term.

A retrospective analysis was performed on the ICH patients between January 2021 and December 2022.

A total of 737 patients were examined with 86 patients (11.7 %) of venous thrombosis. The risk factors linked to venous thrombosis were the length of hospital stay (p<0.001), admission NIH Stroke Scale (p=0.008), and D-dimer levels (p=0.041). No significant differences in mortality rates existed at any timepoint in this study between patients with and without venous thrombosis after correction analysis (p>0.05). However, patients who developed a venous thrombosis exhibited a higher rate of poor outcomes compared to patients who did not develop a venous thrombosis (p<0.05) at the time of hospital discharge (90.7 % vs. 59.6 %), 90 days post-onset (73.2 % vs. 41.6 %), and 1-year post-onset (73.2 % vs. 41.0 %).

The identified risk factors for venous thrombosis among ICH patients include extended hospitalization, elevated NIH Stroke Scale score and D-dimer level. The occurrence of a venous thrombosis correlated with inferior functional outcomes at the time of hospital discharge, at 90 days and 1 year after onset.

## Linked entities

- **Diseases:** intracerebral hemorrhage (MONDO:0013792)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** Hematoma (MESH:D006406), thrombosis (MESH:D013927), inflammatory (MESH:D007249), trauma (MESH:D014947), APACHE II (MESH:C537730), coronary heart disease (MESH:D003327), subarachnoid hemorrhage (MESH:D013345), alcohol (MESH:D000437), ICH (MESH:D002543), death (MESH:D003643), venous thromboembolic disease (MESH:D054556), hypertension (MESH:D006973), neurological damage (MESH:D020196), cancer (MESH:D009369), cerebral infarction (MESH:D002544), gastrointestinal disorders (MESH:D005767), diabetes (MESH:D003920), vascular lesions (MESH:D014652), COVID-19 (MESH:D000086382), atrial fibrillation (MESH:D001281), infection (MESH:D007239), coagulation disorders (MESH:D001778), stoke (MESH:D000219), ICD (OMIM:252500), edema (MESH:D004487), antiphospholipid syndrome (MESH:D016736), DVT (MESH:D020246), Hemorrhage (MESH:D006470), Obesity (MESH:D009765), heart failure (MESH:D006333), intraventricular hemorrhage (MESH:D000074042), hemiplegia (MESH:D006429), tenderness (MESH:D063806), Stroke (MESH:D020521), MIS (MESH:C000718087), PE (MESH:D011655), neurologic deficits (MESH:D009461), APS (MESH:D016884), systemic disease (MESH:D034721), Gastrointestinal bleeding (MESH:D006471), neurologic impairments (MESH:D009422), amyloid angiopathy (MESH:C538248)
- **Chemicals:** Vitamin D (MESH:D014807), D- (MESH:D003903), oxygen (MESH:D010100), uric acid (MESH:D014527), bilirubin (MESH:D001663), triglyceride (MESH:D014280), heparin (MESH:D006493), alcohol (MESH:D000438), enoxaparin (MESH:D017984), glucose (MESH:D005947)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** A1C

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12917554/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12917554/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12917554/full.md

---
Source: https://tomesphere.com/paper/PMC12917554